Literature DB >> 21091355

Coenzyme Q as an antiadipogenic factor.

Sandy Bour1, Maria-Carmen Carmona, Anne Galinier, Sylvie Caspar-Bauguil, Luc Van Gaal, Bart Staels, Luc Pénicaud, Louis Casteilla.   

Abstract

Coenzyme Q (CoQ) is not only the single antioxidant synthesized in humans but also an obligatory element of mitochondrial functions. We have previously reported CoQ deficiency in white adipose tissue of ob/ob mice. We sought to determine (i) whether this deficit exists in all species and its relevance in human obesity and (ii) to what extent CoQ could be involved in adipocyte differentiation. Here we identified in rodents as well as in humans a specific very strong nonlinear negative correlation between CoQ content in subcutaneous adipose tissue and obesity indexes. This striking correlation reveals a threshold value similar in both species. This relative deficit in CoQ content in adipose tissue rapidly took place during the time course of high-fat-diet-induced obesity in mice. Adipocyte differentiation was assessed in vitro using the preadipocyte 3T3-F442A cell line. When CoQ synthesis was inhibited by a pharmacological approach using chlorobenzoic acid, this strongly triggered adipose differentiation. In contrast, adipogenesis was strongly inhibited when a long-term increase in CoQ content was obtained by overexpressing human 4-hydroxy benzoate acid polyprenyltransferase gene. Altogether, these data suggest that a strict level of CoQ remains essential for adipocyte differentiation, and its impairment is associated with obesity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091355     DOI: 10.1089/ars.2010.3350

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  6 in total

1.  Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance.

Authors:  Roland Stocker; David E James; Daniel J Fazakerley; Rima Chaudhuri; Pengyi Yang; Ghassan J Maghzal; Kristen C Thomas; James R Krycer; Sean J Humphrey; Benjamin L Parker; Kelsey H Fisher-Wellman; Christopher C Meoli; Nolan J Hoffman; Ciana Diskin; James G Burchfield; Mark J Cowley; Warren Kaplan; Zora Modrusan; Ganesh Kolumam; Jean Yh Yang; Daniel L Chen; Dorit Samocha-Bonet; Jerry R Greenfield; Kyle L Hoehn
Journal:  Elife       Date:  2018-02-06       Impact factor: 8.140

2.  Omental adipocyte hypertrophy relates to coenzyme Q10 redox state and lipid peroxidation in obese women.

Authors:  Thomas Grenier-Larouche; Anne Galinier; Louis Casteilla; André C Carpentier; André Tchernof
Journal:  J Lipid Res       Date:  2015-08-03       Impact factor: 5.922

3.  The characterization of metabolites alterations in white adipose tissue of diabetic GK Rats after ileal transposition surgery by an untargeted metabolomics approach.

Authors:  Xiaorui Lyu; Kemin Yan; Weijie Chen; Yujie Wang; Huijuan Zhu; Hui Pan; Guole Lin; Linjie Wang; Hongbo Yang; Fengying Gong
Journal:  Adipocyte       Date:  2021-12       Impact factor: 4.534

4.  Coenzyme Q10 Improves Lipid Metabolism and Ameliorates Obesity by Regulating CaMKII-Mediated PDE4 Inhibition.

Authors:  Zhe Xu; Jia Huo; Xin Ding; Mu Yang; Lin Li; Jian Dai; Kazunori Hosoe; Hiroshi Kubo; Masayuki Mori; Keiichi Higuchi; Jinko Sawashita
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

5.  Coenzyme Q10 protected against arsenite and enhanced the capacity of 2,3-dimercaptosuccinic acid to ameliorate arsenite-induced toxicity in mice.

Authors:  Victoria K Mwaeni; James N Nyariki; Ngalla Jillani; George Omwenga; Mathew Ngugi; Alfred Orina Isaac
Journal:  BMC Pharmacol Toxicol       Date:  2021-04-07       Impact factor: 2.483

Review 6.  Mitochondrial dysfunction in obesity: potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndrome.

Authors:  Md Ashraful Alam; Md Mahbubur Rahman
Journal:  J Diabetes Metab Disord       Date:  2014-05-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.